The French penal response to driving under influence (of alcohol or other drugs)
Tendances n°91, OFDT, 8 p.
December 2013
In the French context of increased convictions for crimes and offences (+11% since 2000), the penal response rate has particularly risen for both drug-related offences (over 50,000 convictions per year, or an increase of 119%, and of these convictions, nearly 60% were for use, mainly cannabis use) and road traffic offences (240,000 convictions per year, up 35%, and six in 10 of these convictions were for driving under the influence of alcohol or narcotics). This issue of Tendances examines law enforcement on driving under the influence of alcohol or other drugs, reviewing the most recent trends in road traffic controls and driving under the influence enforcement, as well as the criminal justice system response to these specific alcohol and drug issues. The analysis reveals a conspicuous intensification in roadside traffic controls and arrests as well as an obvious standardisation in the penalties applied to offenders, with higher proportions of fines.
Author:
Ivana Obradovic
Download the PDF file (749 Ko)
Drugs in Europe
2022 EMCDDA European Drug Report
What do the latest data tell us about trends in drug use and the market? What hazardous new drugs are emerging? What substances are posing the greatest health threats? Find out more in the EMCDDA European Drug Report 2022, the latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
